That is the sad reality of BCC, no matter what BOD does, or how many millions they cost shareholders, they will always be the winner.
If share price does well - their free issued shares then appreciate, win. If share price does not do well - their generous salary maintains the lifestyle, win.
It is just discouraging that BCC has become such a stagnant company at this moment. There was so much life and excitement when Zoleo development was underway, look at us now...all the major news updates are about the arbitration process, the growth is minimal, the shareholder-funded cashflow surplus is eaten away by the mistakes of BOD and the arbitration process.
What about the two devices that BCC have been working on / sinking capital into over the past year and a half? We still know nothing about them. Below is the last update, and considering that the launch is fairly soon (2024 2H) there are no hints or marketing to create some excitement and buzz in the market. Hopefully those new products and the conclusion of the arbitration process will get BCC out of the gutter soon.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)